LEO Pharma A/S, a global leader in medical dermatology, announced that the European Commission (EC) has granted marketing authorization for Anzupgo (delgocitinib) cream for the treatment of adult ...

TOKYO, Japan I5, 2024 I Kyowa Kirin Co., Ltd. (Kyowa Kirin) (TSE:4151) (President and CEO: Masashi Miyamoto) announced top-line results of the ...

The European Commission (EC) has granted marketing authorisation to LEO Pharma’s Anzupgo (delgocitinib) cream for treating ...

The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can ...

The U.S. Food and Drug Administration has approved Indianapolis-based Eli Lilly's new treatment for moderate to severe eczema ...

This week, the FDA approved Eli Lilly’s LLY eczema drug, Ebglyss (lebrikizumab), and the expanded use of Novartis’ NVS ...

A mom is raising awareness by sharing pictures of her eleven-year-old daughter's eczema - which has caused pain, itching, and ...

Ebglyss is a new biologic treatment for moderate-to-severe eczema that isn’t controlled with topical therapies. The ...

INDIANAPOLIS–The U.S. Food and Drug Administration has approved Eli Lilly’s new treatment for moderate to severe eczema. It’s ...

By Hector MacKenzie via SWNS A mom is raising awareness by sharing pictures of her eleven-year-old daughter's eczema - which ...

On Friday, the U.S. Food and Drug Administration approved Eli Lilly's eczema drug for use in adults and children 12 and older ...

1-4 CHECK was conducted among 60,131 adult participants from the general ... RWEAL (Real-World trEatment & mAnagement of chronic hand eczema in cLinical practice) study, which examined the ...